Mechanistically, SATB2 functions as a negative regulator of global histone lactylation, with a specific role in reducing histone H3 lysine 9 lactylation (H3K9la)-a previously uncharacterized histone mark in NSCLC. This evidence concerns the gene SATB2 and non-small cell lung carcinoma.